Reference products with biosimilar approvals
RecordSTO-60N9V7K4M1-62PZDBQ1S0-114PD7
United States · 2024
Reference products with biosimilar approvals in the United States were 8 in 2024 (FDA).
Reference products with biosimilar approvals: every country and year, and how it is measured
- Publisher
- FDA
- Authority tier
- T1 Official
- Locator
- A Record Year for Biosimilar Approvals
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
This milestone is due to CDER approving in 2024 a record total of 18 biosimilars for 8 reference products, more than any previous year.
Checked: the figure 8is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
U.S. Food and Drug Administration. (2024). CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024. Retrieved September 17, 2026, from https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Via StatOrigin, https://statorigin.org/stat/stat_60N9V7K4M162PZDBQ1S0114PD7
Other formats: MLA, Chicago, BibTeX
- MLA
- U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024, https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_60N9V7K4M162PZDBQ1S0114PD7.
- Chicago
- U.S. Food and Drug Administration. "CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024." 2024. https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_60N9V7K4M162PZDBQ1S0114PD7.
- BibTeX
- @misc{fda2024reference114pd7, author = {{U.S. Food and Drug Administration}}, title = {CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_60N9V7K4M162PZDBQ1S0114PD7}, note = {Original source: https://www.fda.gov/news-events/fda-voices/cder-brings-many-safe-and-effective-therapies-patients-and-consumers-2024. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- U.S. Food and Drug Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024
- Type
- Press release
- Published
- —
- Locator
- A Record Year for Biosimilar Approvals
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_60N9V7K4M162PZDBQ1S0114PD7